U.S. Neurorehabilitation Devices Market Size & Outlook
The neurorehabilitation devices market in the United States is expected to reach a projected revenue of US$ 1,642.2 million by 2030. A compound annual growth rate of 13% is expected of the United States neurorehabilitation devices market from 2024 to 2030.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. neurorehabilitation devices market is projected to lead the regional market in terms of revenue in 2030.
Canada is the fastest growing regional market in North America and is projected to reach USD 227.8 million by 2030.
More than 130,000 people annually die in the U.S. due to stroke, and it is a leading cause of disability. Furthermore, stroke is accounted as the second largest cause of death, followed by ischemic heart disease.
More than 400,000 people in the U.S. suffer from multiple sclerosis, approximately 60,000 with Parkinson’s disease, and cerebral palsy occurs in 2 to 3 out of 1,000 children. With increasing prevalence and incidence of such neurological disorders in the US, the country promises to be an established market for rehabilitation devices.
The key players of the neurorehabilitation devices market operating in the U.S. are Bioness, Inc.; Ekso Bionics Holdings, Inc.; and Medtronic PLC. These companies provide various kinds of exoskeletons & neurostimulators and other neurorehabilitation products.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Neurorehabilitation Devices Market Outlook will help companies and investors design strategic landscapes.
Neurorobotics was the largest segment with a revenue share of 36.09% in 2023.
Horizon Databook has segmented the U.S. neurorehabilitation devices market based on neurorobotics, brain-computer interface, wearable devices, non-invasive stimulators covering the revenue growth of each sub-segment from 2018 to 2030.
More than 130,000 people annually die in the U.S. due to stroke, and it is a leading cause of disability. Furthermore, stroke is accounted as the second largest cause of death, followed by ischemic heart disease.
More than 400,000 people in the U.S. suffer from multiple sclerosis, approximately 60,000 with Parkinson’s disease, and cerebral palsy occurs in 2 to 3 out of 1,000 children. With increasing prevalence and incidence of such neurological disorders in the US, the country promises to be an established market for rehabilitation devices.
The key players of the neurorehabilitation devices market operating in the U.S. are Bioness, Inc.; Ekso Bionics Holdings, Inc.; and Medtronic PLC. These companies provide various kinds of exoskeletons & neurostimulators and other neurorehabilitation products.
U.S. Neurorehabilitation Devices Market Product Outlook (Revenue, USD Million , 2018-2030)
Neurorobotics
Brain-computer interface
Wearable devices
Non-invasive Stimulators
Others
U.S. Neurorehabilitation Devices Market Therapy Area Outlook (Revenue, USD Million , 2018-2030)
Stroke
Multiple Sclerosis
Parkinson's Disease
Cerebral Palsy
Others
Reasons to subscribe to Neurorehabilitation Devices Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Neurorehabilitation Devices Market Outlook databook
Our clientele includes a mix of Neurorehabilitation Devices Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Neurorehabilitation Devices Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Neurorehabilitation Devices Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.S. Neurorehabilitation Devices Market, 2018-2030 (US$M)